scholarly article | Q13442814 |
P2093 | author name string | Edward A Levine | |
Gregory B Russell | |||
Perry Shen | |||
John H Stewart | |||
Yankai Sun | |||
P2860 | cites work | Cancer statistics, 2008 | Q27860585 |
Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey | Q30004207 | ||
Malignant tumors of the small intestine: a review of 144 cases | Q33826164 | ||
Mucinous adenocarcinoma of the small bowel with peritoneal seeding | Q34546221 | ||
Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients | Q34549580 | ||
Combination chemotherapy in advanced small bowel adenocarcinoma | Q34562516 | ||
Primary cancers of the small bowel: analysis of prognostic factors and results of surgical management | Q34619144 | ||
Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis from small bowel adenocarcinoma | Q36199837 | ||
Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: experience with 501 procedures | Q36811662 | ||
Cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from small bowel adenocarcinoma | Q37526718 | ||
Small bowel cancer: a 30-year review | Q40589425 | ||
Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal origin | Q43596237 | ||
Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome | Q43617379 | ||
Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years | Q43623310 | ||
Chemotherapy with 5-fluorouracil and a platinum compound improves outcomes in metastatic small bowel adenocarcinoma. | Q46401851 | ||
Long-term survivorship and quality of life after cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis. | Q53394963 | ||
Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study | Q73368601 | ||
Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis | Q78743915 | ||
P433 | issue | 6 | |
P921 | main subject | peritoneal carcinomatosis | Q2071182 |
adenocarcinoma | Q356033 | ||
chemotherapy | Q974135 | ||
P304 | page(s) | 644-648 | |
P577 | publication date | 2013-06-01 | |
P1433 | published in | American Surgeon | Q15766266 |
P1476 | title | Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from small bowel adenocarcinoma | |
P478 | volume | 79 |
Q41041625 | A Novel Tool for Predicting Major Complications After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy |
Q35817844 | Cytoreduction and HIPEC in the treatment of "unconventional" secondary peritoneal carcinomatosis |
Q52683901 | Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastases From a Small Bowel Adenocarcinoma: Multi-Institutional Experience. |
Q37662806 | Intraperitoneal chemotherapy for peritoneal surface malignancy: experience with 1,000 patients |
Q41454278 | Peritoneal metastases of rare carcinomas treated with cytoreductive surgery and HIPEC - A single center case series |
Q37225339 | Retrospective analysis on the safety of 5,759 times of bedside hyperthermic intra-peritoneal or intra-pleural chemotherapy (HIPEC) |
Q92617988 | Uncommon indications for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy |
Search more.